Multiple sclerosis is characterized pathologically by inflammation, demyelination, gliosis and axonal injury. Notably, the fate of oligo dendrocytes can vary widely in multiple sclerosis lesions, from widespread oligodendrocyte cell death to preservation of most oligo dendrocytes 1 . Actively demyelinating multiple sclerosis lesions have been tentatively separated into three patterns, comprising the vast majority of analyzed biopsy material 1,2 . It has been proposed that patterns I and II are driven mainly by inflammatory processes, with relatively low levels of oligodendrocyte cell loss, and can be effec tively modeled by experimental autoimmune encephalomyelitis (EAE) 3 . In contrast, pattern III lesions are suggested to occur when oligodendrocytes are subjected to environmental factors (viral or chemical) that produce metabolic stress. Oligodendrocyte cell loss is proposed to occur after additional pathological processes involv ing inflammation 1,2 . Although there is ongoing discussion whether these lesion patterns represent discrete subtypes of multiple scle rosis or temporal evolution of the disease, investigators agree that neuropathologically distinct, actively demyelinating multiple sclerosis lesions can be observed 4 . Animal models of pattern III lesions have not been validated 5 .
Multiple sclerosis is characterized pathologically by inflammation, demyelination, gliosis and axonal injury. Notably, the fate of oligo dendrocytes can vary widely in multiple sclerosis lesions, from widespread oligodendrocyte cell death to preservation of most oligo dendrocytes 1 . Actively demyelinating multiple sclerosis lesions have been tentatively separated into three patterns, comprising the vast majority of analyzed biopsy material 1, 2 . It has been proposed that patterns I and II are driven mainly by inflammatory processes, with relatively low levels of oligodendrocyte cell loss, and can be effec tively modeled by experimental autoimmune encephalomyelitis (EAE) 3 . In contrast, pattern III lesions are suggested to occur when oligodendrocytes are subjected to environmental factors (viral or chemical) that produce metabolic stress. Oligodendrocyte cell loss is proposed to occur after additional pathological processes involv ing inflammation 1, 2 . Although there is ongoing discussion whether these lesion patterns represent discrete subtypes of multiple scle rosis or temporal evolution of the disease, investigators agree that neuropathologically distinct, actively demyelinating multiple sclerosis lesions can be observed 4 . Animal models of pattern III lesions have not been validated 5 .
Pattern III lesions of multiple sclerosis might involve 'dying back gliopathy', as the distal elements of oligodendrocyte processes show the earliest signs of degeneration 6 . Feeding mice the copper chelator cuprizone (bis(cyclohexylidenehydrazide)) inhibits mito chondrial function 7 and causes CNS demyelination 8 . More than 25 years ago, dyingback gliopathy in cuprizoneinduced demyeli nation was described 9 . Cuprizoneinduced demyelination lesions have additional similarities with pattern III lesions of multiple sclerosis, including indistinct lesion borders and abundant accu mulation of lesional microglia, but only a sparse hematogenous leukocyte response 2, 10, 11 .
Early findings using the cuprizone model suggested a direct cell autonomous toxicity to oligodendrocytes 7 . This hypothesis was refuted by three pieces of evidence. First, cuprizone exposure to primary oligo dendrocytes in vitro causes metabolic stress, but not cell death, unless cultures are supplemented with inflammatory cytokines 12, 13 . Second, myelin basic protein (MBP)-IFNγ transgenic mice are relatively resistant to cuprizoneinduced demyelination, although oligodendro cytes have reduced myelin protein mRNA expression, indicating that they are undergoing metabolic stress 14 . Third, B6 mice lacking the neuronal nitric oxide synthase (nNOS, NOSI) are relatively resist ant to cuprizoneinduced demyelination 15 . Together, these findings suggest that oxidative/nitrative stress causes mitochondrial impair ment and nNOS is involved in cuprizoneinduced demyelination. Experimental studies using genetargeted mice have also shown that inflammatory mediators are involved in the kinetics of cuprizone induced demyelination or myelin repair 16, 17 .
CXCR2 has been implicated in inflammation, oligodendroglial biology and myelin disorders 18 . In the developing spinal cord, CXCR2 is required for accurate positioning and timely prolifera tion of oligodendrocyte progenitor cells (OPCs) 19, 20 . Mice lack ing CXCR2 are relatively resistant to EAE, although T cells from Cxcr2 −/− mice have vigorous myelinspecific recall responses and EAE susceptibility is recovered by transfer of CXCR2positive neutro phils 21 . Cxcr2 −/− and Cxcr2 +/+ mice on a BALB/c background were equally susceptible to cuprizone, but these mice showed only very a r t I C l e S modest demyelination, reflecting the known cuprizoneresistance of BALB/c mice 22 . Attempts were made to immunolocalize CXCR2, but the antibodies were subsequently found to be nonspecific 22 .
We placed the Cxcr2 −/− targeted allele on the cuprizonesusceptible B6 background to evaluate the role of CXCR2 in toxininduced inflammatory demyelination, caused by either cuprizone feeding or lysolecithin (LPC) injection. We found that demyelination in the cuprizone model was contingent on CXCR2 positive neutrophils, suggesting a twostep mechanism for oligodendrocyte cell loss. We suggest that cuprizoneinduced inhibition of mitochondrial function in oligodendro cytes, along with nitrative stress associated with nNOS activity in CNSresident cells, induces metabolic stress and vulnerability to apoptotic cell death, followed by a 'second hit' that requires functions delivered by CXCR2 positive bloodderived neutrophils. Our find ings extend the utility of cuprizoneinduced demyelination as a productive model for pattern III lesions of multiple sclerosis.
RESULTS

Cxcr2 −/− mice: failure of cuprizone-induced demyelination
We compared the effects of cuprizone feeding in Cxcr2 +/+ and Cxcr2 −/− mice. On the B6 background, Cxcr2 +/+ mice showed robust demyelination following cuprizone feeding, which allowed us to read ily discern differences between Cxcr2 +/+ and Cxcr2 −/− mice. Cxcr2 −/− mice were resistant to cuprizoneinduced demyelination as compared with Cxcr2 +/+ mice after 6 weeks of cuprizone feeding (Fig. 1) . We carried out toluidine blue staining (Supplementary Fig. 1 ) and elec tron microscopy studies after 4 weeks (Fig. 1) to evaluate early active demyelination and found marked differences between Cxcr2 +/+ and Cxcr2 −/− mice.
Cuprizoneinduced demyelination follows a stereotyped time course in B6 mice. Initial changes are observed after 1-2 weeks of cuprizone feeding, when myelin protein mRNAs are reduced by 75% 23 . Oligodendrocyte cell loss is observed by 3 weeks, accompanied by the first signs of demyelination. The peak accumulation of inflam matory cells, comprised of microglia (~90%) and hematogenous cells (~10%), is seen at 4 weeks 11 . By 6 weeks, the corpus callosum shows maximal demyelination. Remyelination is observed 2-4 weeks after resuming a cuprizonefree diet 8 .
We evaluated whether cuprizone caused acute toxic effects and cell death of oligodendrocytes in Cxcr2 +/+ and Cxcr2 −/− mice. After 1 or 2 weeks of cuprizone feeding, we found that mRNA encoding a r t I C l e S the myelin proteins MBP and 2′,3′cyclic nucleotide 3′phosphodiesterase (CNPase) in the corpus callosum were equivalently and severely reduced in both Cxcr2 −/− and Cxcr2 +/+ mice (Fig. 2a) , indicating that cuprizone induced metabolic toxicity in oligo dendrocytes in both groups of mice equally. At 3 and 4 weeks, however, myelin protein mRNAs showed a substantial and significant rebound (P < 0.01) in the corpus callosum of Cxcr2 −/− , but not Cxcr2 +/+ , mice, despite continuous cuprizone feeding of both groups (Fig. 2a) . These results suggest that damage to oligodendrocytes in Cxcr2 +/+ mice was severe and irreversible, whereas it was transient in Cxcr2 −/− mice. We tested this hypothesis by TUNEL assay and found that the number of apoptotic cells in Cxcr2 +/+ mice was sig nificantly elevated (P < 0.01) over controls after 3 weeks of cuprizone feeding (Fig. 2b,c) . Furthermore, electron microscopy imagery revealed nuclei that were morphologically consistent with apoptotic cells in the corpus callosum of Cxcr2 +/+ mice after 4 weeks of cuprizone feeding (Supplementary Fig. 2 ). These results correlated well with the relative resistance to demyelination in cuprizonefed Cxcr2 −/− mice.
Responses of the oligodendrocyte lineage to cuprizone
We recently found that CXCR2 antagonists accelerate myelin repair 24 .
To address the possibility that cuprizonefed Cxcr2 −/− mice undergo rapid demyelination and myelin repair, we evaluated mice with black gold myelin staining after 1, 2, 3 and 6 weeks of cuprizone feeding ( Fig. 1 ) and found no evidence of myelin damage or repair in Cxcr2 −/− mice. Supporting this interpretation, the G ratios of the remaining myelinated fibers in the corpus callosum of Cxcr2 +/+ and Cxcr2 −/− mice after 4 weeks of cuprizone feeding were not different and were equal to those of control mice ( Supplementary Fig. 3 ), indicating that remyelination had not extensively occurred in either Cxcr2 +/+ or Cxcr2 −/− mice by the 4week time point. We then analyzed the oligodendrocyte lineage during the early phase of cuprizone feeding.
As previously reported 8 , we found that 3 weeks of cuprizone feeding caused severe (>75%) loss of GSTπ-positive cells in the affected corpus callosum of Cxcr2 +/+ mice ( Fig. 3) , whereas Cxcr2 −/− mice showed only moderate (<50%) loss of GSTπ-positive cells at the same time point (Fig. 3) . In contrast, both groups of mice showed modest and equivalent loss of GSTπ-positive cells at 2 weeks. These findings correlated with the time course of appearance of apoptotic cells in the corpus callosum and suggest that GSTπ-positive oligodendrocytes are lost via apoptosis (Fig. 2b,c) and that the expression of the GSTπ marker is possibly diminished. We evaluated PDGFRαpositive cells, which represent oligodendrocyte progenitor cells (OPCs), at weeks 1-3 and week 6 to determine whether cuprizone affected all of the cells of the lineage equally. Cxcr2 +/+ and Cxcr2 −/− mice had equivalent initial numbers of PDGFRαpositive cells, which were significantly (P < 0.01) and equally reduced after 1 and 2 weeks of cuprizone feeding but rose by more than 300% in Cxcr2 +/+ mice after 6 weeks of cuprizone feeding (Fig. 3) . Analysis of Olig2positive cells (representing both mature oligo dendrocytes and OPCs) reflected the summation of these changes in GSTπ-positive mature oligodendrocytes and PDGFRαpositive OPCs (Fig. 3) . We concluded that cuprizone caused widespread apoptotic death of mature oligodendrocytes in the corpus callosum of Cxcr2 +/+ , but not Cxcr2 −/− , mice. The proliferative reaction of PDGFRαpositive cells in the corpus callosum of Cxcr2 +/+ mice after 3 and 6 weeks of cuprizone feeding may be a response to demyelination, which was robust in Cxcr2 +/+ mice (Fig. 3) . Notably, there was no change in the number or appearance of PDGFRαpositive OPCs in the adjacent cortex across the time course of cuprizone feeding in either Cxcr2 +/+ or Cxcr2 −/− mice ( Supplementary Fig. 4 ). This observation provided an internal technical control for the immunostaining and suggests that OPCs involved in the reparative tissue reaction to cuprizoneinduced demyelination in B6 mice might be derived from sources other than tissue adjacent to the corpus callosum. , and we propose a twohit model for cuprizoneinduced demyelination. We addressed the corollary hypothesis that myeloid CXCR2positive cells might be required for demyelination in this model. Initially, we exam ined the possibility that CNS microglia (derived from the myeloid lineage 25 ) might express CXCR2, as was recently suggested on the basis of immunohistochemistry 22 . Using flow cytometry, we confirmed that the commercial antibodies used were nonspecific for CXCR2, as was noted previously 22 . In particular, commercial antibodies failed to stain CXCR2positive, Gr1positive myeloid cells in flow cytometry assays ( Supplementary Fig. 5 ) but equally stained both brain and splenic tissue sections from Cxcr2 +/+ and Cxcr2 −/− mice (data not shown). Using validated polyclonal monospecific antibodies 21 , we found that CD45 dim microglia did not express CXCR2 (Supplementary Fig. 6 ).
The responses of Cxcr2 +/+ and Cxcr2 −/− mice to cuprizone began to diverge markedly at 3 weeks of feeding (Figs. 1-3) , corresponding to the onset of substantial cellular inflammation, including microglial proliferation and infiltration of CD11bpositive myeloid hemato genous cells 11 . Given the lack of CXCR2 expression by microglia, we focused our attention on CXCR2positive myeloid circulating cells. Radiation bonemarrow chimeras were generated to address whether the presence of CXCR2 on hematogenous myeloid cells was involved in cuprizoneinduced demyelination. We used Cxcr2 +/− mice as donors for Cxcr2 +/+ or Cxcr2 −/− mice, as our colony was maintained using heterozygous breeders. This approach enabled direct compari son of littermates in experiments. Chimerism was analyzed 6 weeks after bonemarrow transfer and we found that blood cells exhibited the heterozygous genotype of the marrow donor mice (data not shown). We found a population of circulating Gr1positive, CXCR2 positive myeloid cells in the Cxcr2 +/+ mice (Supplementary Fig. 7) . In Cxcr2 −/− mice, we found an expanded Gr1positive, CXCR2negative population among the myeloid cells (Supplementary Fig. 7) , which has been seen previously 26 . Both Cxcr2 +/− →Cxcr2 +/+ and Cxcr2 +/− → Cxcr2 −/− chimeric mice had similar Gr1positive, CXCR2positive myeloid cell populations when evaluated 6 weeks after chimeriza tion (Supplementary Fig. 7) . These results indicate that the myeloid compartment in Cxcr2 +/− →Cxcr2 +/+ and Cxcr2 +/− →Cxcr2 −/− mice was recovered after bonemarrow transfer and that virtually all of the circulating CXCR2positive cells were Gr1positive myeloid cells.
Given the complexity of radiation chimerism as an experimental model 27 , we evaluated several control groups. Findings of equal demyelination in Cxcr2 +/+ and Cxcr2 +/+ →Cxcr2 +/+ mice indicated that radiation chimerism did not modulate cuprizoneinduced demyelination (Fig. 4a,b) , consistent with previous results 28 . An effect of haploinsufficiency at CXCR2 was excluded by the observation that Cxcr2 +/− and Cxcr2 +/+ mice developed an equal extent of demyelination (Fig. 4a,b) . After 6 weeks of cuprizone feeding, the amount of cuprizone induced demyelination in Cxcr2 +/− →Cxcr2 −/− chimeric mice was equal to that of Cxcr2 +/− →Cxcr2 +/+ mice (Fig. 4a,b) , suggesting that replacement of the CXCR2positive myeloid cells compartment reversed resistance to cuprizoneinduced demyelination. Observations using blackgold staining were confirmed by electron microscopy analysis (Fig. 4c,d) . Cxcr2 +/− →Cxcr2 +/+ chimeric mice were gener ated and studied both in comparison with Cxcr2 +/− →Cxcr2 −/− chi meric mice and in comparison with Cxcr2 +/+ mice, with reproducible results (Fig. 4a,b) . We found equal G ratios in Cxcr2 +/+ and Cxcr2 −/− mice (Supplementary Fig. 3) , as well as in residual myelinated axons of Cxcr2 +/− →Cxcr2 +/+ and Cxcr2 +/− Cxcr2 −/− mice after 4 weeks of cuprizone feeding (Fig. 4e) . These observations indicate that myelin loss after 4 weeks was solely the result of demyelination, as there was no evidence for substantial remyelination in the chimeras after 4 weeks of cuprizone feeding. The most straightforward interpretation of our data is that CXCR2positive myeloid cells are required for oligo dendrocyte cell loss and demyelination after cuprizone challenge.
No demyelination in Cxcr2 −/− →Cxcr2 +/+ mice Our findings raised the question of whether the absence of CXCR2 on myeloid cells was sufficient to render mice resistant Figure 4 Cxcr2 +/− →Cxcr2 −/− and Cxcr2 +/− →Cxcr2 +/+ chimeric mice exhibited equal levels of cuprizone-induced demyelination. (a,b) Radiation bone-marrow chimeras, Cxcr2 +/+ , Cxcr2 +/− and Cxcr2 −/− mice were fed cuprizone and analyzed for demyelination of the corpus callosum. Panels in a are representative of corresponding groups shown in b. We evaluated the effects of chimerization by comparing Cxcr2 +/+ and Cxcr2 +/+ →Cxcr2 +/+ mice. The effects of haploinsufficiency on the response to cuprizone were assessed by comparing Cxcr2 +/+ and Cxcr2 +/− mice and by comparing Cxcr2 +/+ →Cxcr2 +/+ and Cxcr2 +/− →Cxcr2 +/+ mice (b). Two separate cohorts of Cxcr2 +/− →Cxcr2 +/+ mice were prepared and analyzed (b). Scale bar represents 250 µm in a. (c-e) Cxcr2 +/− →Cxcr2 −/− mice were susceptible to cuprizone-induced demyelination, which we confirmed using electron microscopy. Cxcr2 +/− →Cxcr2 +/+ and Cxcr2 +/− →Cxcr2 −/− mice were fed cuprizone for 4 weeks and we then analyzed the rostral corpus callosum by electron microscopy (c) and quantified axon myelination and G ratios in the corpus callosum (d,e). NS, not significant (P > 0.05). Scale bar represents 2 µm in c. (Fig. 5) . By quantitative analysis, we found significantly more GSTπ-positive oligodendro cytes in the corpus callosum of Cxcr2 −/− →Cxcr2 +/+ mice than in that of Cxcr2 +/+ →Cxcr2 +/+ mice after 4 weeks of cuprizone feeding (P < 0.001; Fig. 5 ). In addition, in Cxcr2 −/− →Cxcr2 +/+ mice, the secondary inflammatory reactions to cuprizoneinduced oligo dendrocyte cell loss were also limited (Fig. 5) . In summary, Cxcr2 −/− → Cxcr2 +/+ mice recapitulated the phenotype of Cxcr2 −/− mice in cupri zoneinduced demyelination. Taken together, our results indicate that CXCR2positive peripheral blood cells are essential for cuprizone induced demyelination. For these experiments (Fig. 5) , cuprizone feeding was terminated after 4 weeks, as Cxcr2 −/− →Cxcr2 +/+ mice showed relatively high mortality during the chimerization protocol and lost body weight during cuprizone feeding. Nevertheless, on a weighttoweight basis, Cxcr2 −/− →Cxcr2 +/+ mice consumed an equivalent amount of cuprizonesupplemented chow, as did Cxcr2 +/+ →Cxcr2 +/+ mice. Successful Cxcr2 −/− →Cxcr2 +/+ chimerization was verified by flow cytometry (Supplementary Fig. 8 ). We propose that the weight loss in Cxcr2 −/− →Cxcr2 +/+ chimeric mice, which came to resemble Cxcr2 −/− mice in size, was probably caused by poor host defense against gastro intestinal flora as a result of incompetent neutrophil migration or effector response 29 .
Impaired neutrophil effector functions in Cxcr2 −/− mice CXCR2 has been detected on various myeloid cells in vitro. We analyzed blood cells from Cxcr2 +/+ mice and found that all of the Ly6Gpositive neutrophils were CXCR2 positive and that all of the CXCR2positive cells were neutrophils (Fig. 6) . Therefore, the biologi cal effects of CXCR2 on myeloid cells in Cxcr2 +/+ mice were restricted to neutrophils. We then performed kinetic analysis of myeloid cell entry into the corpus callosum of Cxcr2 +/+ mice after 3, 5, 7 and 9 d of cuprizone feeding and at 6 weeks. The percentage of CD45 int , Ly6Gpositive neutrophils increased substantially at day 7 from 1.2%
(control) to 6.06% of the total population of cells isolated from the CNS. We stained for F4/80, a macrophage marker, and found that the Ly6Gpositive population was uniformly negative, confirming that these cells were neutrophils and not macrophages. The presence of the myeloid marker Gr1 (Ly6C/Ly6G) correlated with the presence of Ly6G, indicating that most early infiltrating myeloid cells were neutro phils in this model (Fig. 7) . We compared Cxcr2 +/+ and Cxcr2 −/− mice in a subsequent experiment after 5 d of cuprizone feeding, the earliest point at which Cxcr2 +/+ mice showed substantial entry of neutrophils into the CNS. Cxcr2 −/− mice, which harbored an elevated number of neutrophils in the CNS at baseline, had a large population of CD45 int , Ly6Gpositive and CXCR2negative neutrophils in the CNS at this time point. Notably, the fold increase of neutrophils over control (about fivefold) and the percent of total CD45 int/hi infiltrating cells represented by neutrophils at 5 d (27-30%) were equivalent in the Cxcr2 +/+ and Cxcr2 −/− mice (Fig. 8) . We concluded that there was no recruitment deficit for neutrophils to the CNS of cuprizonefed Cxcr2 −/− mice and that the demyelinationresistant phenotype was caused by deficient neutrophil effector responses.
To determine the role of early infiltrated neutrophils in cuprizone induced demyelination in Cxcr2 +/+ mice, we depleted neutrophils using antibodies to Gr1 (RB68C5) starting 2 d before cuprizone feeding. Neutrophils depletion was verified by flow cytometry and persisted for 1 week (Supplementary Fig. 9 ). After 3 weeks of cuprizone feed ing, neutrophildepleted mice had fewer apoptotic cells in corpus callosum than mice injected with control antibodies (Supplementary  Fig. 9 ). These data indicate that the presence of neutrophils in the CNS, as well as effector functions regulated by CXCR2, were essential for cuprizoneinduced demyelination.
Similar demyelination in LPC-injected spinal cord
Cxcr2 −/− mice are resistant to both EAE 21 and cuprizoneinduced demyelination (Fig. 1) , raising the question of whether CXCR2 a r t I C l e S deficiency precludes detection or development of demyelinating CNS lesions. Injection of LPC into the dorsal columns of the thoracic spi nal cord causes demyelination, with fully developed lesions at 2 d postinjection 30 . LPC injections to Cxcr2 +/+ or Cxcr2 −/− mice caused an equivalent demyelinating lesion after 1, 2 and 3 d (Supplementary  Fig. 10 ). Thus, LPSinduced demyelination can be readily observed without CXCR2 signaling.
DISCUSSION
We found that Cxcr2 −/− mice were relatively resistant to cuprizone induced demyelination. This requirement for CXCR2 for toxininduced demyelination was selective for the cuprizone model, as Cxcr2 −/− mice were susceptible to LPCmediated demyelination. The results of our studies using bone marrow chimeras indicate that CXCR2positive neutrophils from the bloodstream are necessary for cuprizone induced demyelination, as Cxcr2 −/− →Cxcr2 +/+ and Cxcr2 −/− mice were equally refractory to demyelination. Furthermore, CXCR2positive neutrophils were sufficient to confer full susceptibility to demyelina tion in Cxcr2 +/− →Cxcr2 −/− chimeras. Unexpectedly, we found that a brief burst of peripheral leukocyte infiltration of the corpus callosum at 5-7 d of cuprizone feeding that was characterized by CD45 int , Ly6G, Gr1 and CXCR2positive neutrophils, whose effector func tions were required for cuprizoneinduced demyelination. These results indicate that CXCR2 has nonredundant functions in cuprizone induced demyelination, which are not compensated for by CXCR1.
As a corollary, it seems likely that CXCR2 ligands (rather than dual CXCR1/CXCR2 ligands) will be associated with this pathology.
It was important to exclude the possibility that Cxcr2 −/− mice under went accelerated demyelination/remyelination in response to cupri zone feeding. Several of our results address this. First, histochemical staining across the time course of cuprizone feeding failed to reveal early demyelination in Cxcr2 −/− mice. Second, using electron micro scopy analysis at 4 weeks, we found no evidence of extensive remy elination in Cxcr2 −/− mice, as the G ratios of myelinated fibers were equal to those seen in control mice. Third, apoptotic cells were not present at 1-3 weeks in the corpus callosum of Cxcr2 −/− mice, as deter mined by TUNEL staining. Fourth, analysis of the oligodendrocyte In comparison with control, the number of CD45 int , Ly6G-positive neutrophils increased substantially at day 7 (left). The Ly6G-positive population was uniformly negative for F4/80 (middle of each group). The presence of the myeloid marker Gr1 (Ly6C) was correlated with the presence of Ly6G (right of each group). Each group consisted of two mice. These data represent three separate experiments. a r t I C l e S lineage revealed that the CXCR2 wildtype mice lost significantly more (P < 0.05) GSTπ-positive cells (at 3 weeks) and showed much more proliferation of PDGFRαpositive cells after 3 and 6 weeks of cuprizone feeding than did the knockouts.
Our results describe the complexity of the response of the oligoden droglial lineage to cuprizone, indicating that GSTπ-positive mature oligodendrocytes were extensively lost at 3 weeks via apoptosis and that in situ proliferation of PDGFRαpositive OPCs was the probable source of oligodendrocyte renewal. These findings can be extended by identifying the source of callosal OPCs that proliferate after demy elination. Our preliminary results argue that OPCs are derived from the progeny of neuronal progenitor cells in the subependymal zone (L.L., L.D., R.M.R., unpublished observations).
Using bonemarrow chimeras, we found that CXCR2 + neutrophils were both necessary and sufficient for cuprizoneinduced demyeli nation. Antibodymediated depletion studies complemented these observations (Supplementary Fig. 9 ). Given these findings and the lack of CXCR2 on microglial cells (Supplementary Fig. 6 ), we conclude that the action of CXCR2 toward resident CNS cells probably did not cause cuprizone resistance in Cxcr2 −/− mice. Our studies represent the first demonstration, to the best of our knowl edge, that peripheral circulating cells are essential for cuprizone induced demyelination.
Mice lacking nNOS were resistant to cuprizoneinduced demyelina tion, which was accompanied by a preservation of oligodendrocyte numbers, reduced oligodendrocyte apoptosis and minimal tissue reaction 15 . The requirement for nNOS activity for cuprizoneinduced demyelination is a result of its function in the CNS, as murine nNOS is expressed selectively in the nervous system (http://www.ncbi.nlm. nih.gov/UniGene/ESTProfileViewer.cgi?uglist=Mm.44249), and Nos1 −/− mice do not exhibit abnormalities in immunity or inflam mation. Furthermore, in contrast with Cxcr2 −/− mice, cuprizone exposed Nos1 −/− mice showed only very modest reduction myelin protein mRNA expression in the corpus callosum. We interpret these results as indicating that CNS nNOS activity is required for induc ing metabolic stress of oligodendrocytes during the early phases of cuprizoneinduced demyelination.
The cuprizoneresistant phenotype of Cxcr2 −/− mice was most rem iniscent of that of MBP-IFNγ transgenic mice, which overexpress modest amounts of IFNγ in the CNS under the control of the Mbp promoter 14 . Both Cxcr2 −/− and MBP-IFNγ transgenic mice demon strate preservation of oligodendrocytes and lack of tissue reaction after cuprizone feeding. Early reduction of myelin protein mRNAs occurred equally in wildtype mice destined to develop demyelina tion and in MBP-IFNγ transgenic mice or Cxcr2 −/− mice, which were resistant. Myelin protein mRNAs returned to normal levels at 3 and 4 weeks of cuprizone feeding in Cxcr2 −/− , but not MBP-IFNγ transgenic mice, possibly because IFNγ also delays remyelination by inducing endoplasmic reticulum stress 31 . It has been suggested 14 that elevated levels of insulinlike growth factor 1 might account for the resistance of MBP-IFNγ transgenic mice to cuprizoneinduced demyelination. However, overexpression of insulinlike growth factor 1 in transgenic mice does not preclude demyelination, making this explanation less plausible 32 .
Another IFNγ-mediated effect may help to explain resistance to cuprizone in transgenic mice 33 . Specifically, in both viral and auto immune models, IFNγ is critical for neuroinflammation by restraining the production of CXCR2 ligands such as CXCL1 and CXCL2, thereby limiting invasion of the CNS by neutrophils [34] [35] [36] [37] . It is tempting to speculate that MBP-IFNγ transgenic mice resist cuprizoneinduced demyelination, and resemble Cxcr2 −/− mice in this regard, at least in part because production of CXCR2 ligands is blocked by IFNγ. We do not address which CXCR2 ligands are implicated in cupri zoneinduced demyelination or their cellular source. By analogy with pathologies of other models such as EAE and viral encephalitis, it seems most likely that local reactive astrocytes produce CXCL1 and CXCL2 during cuprizoneinduced demyelination. Previous micro array studies support this hypothesis 23 .
Our findings suggest that the interaction of neurotoxic and inflam matory mechanisms in the cuprizonefeeding model of demyelination should be reconsidered. As a mitochondrial toxin, cuprizone provides a model for studying mitochondrial impairment in multiple sclerosis pathogenesis 38 and compromised mitochondrial function in pattern III lesions in particular 39 . We propose that, in both cuprizoneinduced demyelination and pattern III multiple sclerosis lesions, mitochon drial impairment increases reactive oxygen species generation and renders oligodendrocytes vulnerable to apoptosis. We hypothesize that neuronal nNOS activity leads to additional oxidative/nitrative stress. Finally, CXCR2positive neutrophils from the circulation also produce reactive oxygen species. The interaction of mitochondrial impairment and oxidative/nitrative stress is widely studied in neurodegenerative diseases 40 and is considered to be the probable cause, in part, of the axonal pathology in multiple sclerosis 41 . Our findings suggest that this pathway also leads to demyelination in selected settings.
In cuprizoneinduced demyelination, lesion formation follows the loss of oligodendrocytes. The requirement for CXCR2positive neutrophils to produce both oligodendrocyte cell loss and demyeli nation confirms that direct cuprizone toxicity is necessary, but not sufficient, for this pathological process in vivo. In cuprizoneinduced demyelination, the second hit required for oligodendrocyte loss is contingent on CXCR2positive neutrophils. In Cxcr2 −/− mice, the neutrophil compartment is abnormally expanded and distributed aberrantly throughout tissues, including the CNS. Signaling to CXCR2 governs a wide array of neutrophil effector functions, including gene expression and degranulation. Therefore, we consider it likely that CXCR2 affects cuprizoneinduced demyelination by promoting the effector functions of infiltrated neutrophils in the CNS.
Recent EAE studies have shown that CXCR2positive neutrophils are required for disease pathogenesis 21 . EAE is considered to be a useful model for examining immune and inflammatory mechanisms of multiple sclerosis lesions. Our findings establish a foundation for characterizing bloodderived CXCR2positive neutrophils implicated in cuprizoneinduced demyelination and for determining either which neutrophil functions contribute to oligodendrocyte cell loss or which protective functions are exerted by Cxcr2 −/− cells. By extension, this information should provide useful insights for limiting tissue damage in pattern IIItype demyelinating diseases of the CNS.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
